https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-11-03 / BMJ Open 2017 Nov;7(11):e017387
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-11-03 / BMJ Open 2017 Nov;7(11):e0173872017-11-03 00:00:002017-11-03 00:00:00Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-11-01 / Cancer Immunol. Immunother. 2018 02;67(2):285-298
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-11-01 / Cancer Immunol. Immunother. 2018 02;67(2):285-2982017-11-01 00:00:002019-02-15 08:49:51A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-31 / Curr Probl Cancer 2018;42(1):49-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-31 / Curr Probl Cancer 2018;42(1):49-582017-10-31 00:00:002017-10-31 00:00:00Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-24 / Sci Rep 2017 10;7(1):13902
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-24 / Sci Rep 2017 10;7(1):139022017-10-24 00:00:002021-11-15 20:01:44Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-20 / Biochem. Biophys. Res. Commun. 2017 12;494(1-2):13-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-20 / Biochem. Biophys. Res. Commun. 2017 12;494(1-2):13-192017-10-20 00:00:002019-02-15 08:52:23MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-19 / Eur Urol Focus 2018 04;4(3):442-454
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-19 / Eur Urol Focus 2018 04;4(3):442-4542017-10-19 00:00:002022-09-27 09:05:10Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-18 / Biochim Biophys Acta Rev Cancer 2017 Dec;1868(2):538-563
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-18 / Biochim Biophys Acta Rev Cancer 2017 Dec;1868(2):538-5632017-10-18 00:00:002017-10-18 00:00:00Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-17 / Breast Cancer Res Treat 2018 01;167(2):591-598
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-17 / Breast Cancer Res Treat 2018 01;167(2):591-5982017-10-17 00:00:002017-10-17 00:00:00Serum selenium levels predict survival after breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-03 / Biomaterials 2018 Jan;150:112-124
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-03 / Biomaterials 2018 Jan;150:112-1242017-10-03 00:00:002017-10-03 00:00:00Rethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-01 / Am J Cancer Res 2017;7(10):2091-2102
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-01 / Am J Cancer Res 2017;7(10):2091-21022017-10-01 00:00:002019-02-15 08:47:56Dendritic cells based immunotherapy
